1. Home
  2. TLIH vs LPCN Comparison

TLIH vs LPCN Comparison

Compare TLIH & LPCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ten-League International Holdings Limited Ordinary Shares

TLIH

Ten-League International Holdings Limited Ordinary Shares

N/A

Current Price

$5.79

Market Cap

16.9M

Sector

N/A

ML Signal

N/A

Logo Lipocine Inc.

LPCN

Lipocine Inc.

BUY

Current Price

$1.68

Market Cap

18.7M

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
TLIH
LPCN
Founded
1998
1997
Country
Singapore
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
16.9M
18.7M
IPO Year
2023
2011

Fundamental Metrics

Financial Performance
Metric
TLIH
LPCN
Price
$5.79
$1.68
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
★ $5.00
AVG Volume (30 Days)
2.0K
★ 1.5M
Earning Date
09-30-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $1,976,677.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$18.02
P/E Ratio
$3.34
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$0.22
$1.59
52 Week High
$6.08
$12.37

Technical Indicators

Market Signals
Indicator
TLIH
LPCN
Relative Strength Index (RSI) 54.22 30.07
Support Level $5.14 N/A
Resistance Level $5.87 $2.40
Average True Range (ATR) 0.15 0.19
MACD -0.00 -0.05
Stochastic Oscillator 93.75 5.13

Price Performance

Historical Comparison
TLIH
LPCN

About TLIH Ten-League International Holdings Limited Ordinary Shares

Ten-League International Holdings Ltd is a Singapore-based provider of turnkey project solutions. Its business consists of sales of heavy equipment and parts, heavy equipment rental, and provision of engineering consultancy services to port, construction, civil engineering, and underground foundation industries. It currently conducts its operations through its wholly-owned subsidiaries. The equipment it provides is organized into four categories based on their functions and application scenarios, namely, foundation equipment, hoist equipment, excavation equipment, and port machinery. The company operates in Singapore and Other international countries.

About LPCN Lipocine Inc.

Lipocine Inc is a clinical-stage biopharmaceutical company that is engaged in research and development for the delivery of drugs using its proprietary delivery technology. Its principal operation is to provide oral delivery solutions for existing drugs. Lipocine develops its drug candidates, or it develops drug candidates on behalf of or in collaboration with corporate partners. The company's product TLANDO is an oral testosterone replacement therapy (TRT). It also has other products in the pipeline, such as LPCN 1144, TLANDO, TLANDO XR, LPCN 1148, LPCN 1107, LPCN 1154, and LIP RAL7 Technology. The Company has a single reportable segment, research, and development for the delivery of drugs using its proprietary delivery technology.

Share on Social Networks: